JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
HALO - Halozyme Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary HALO Stock
Financials
Financials HALO Stock
Loading...
Loading...
HALO Stock Price & Analysis - Halozyme Therapeutics | Ledgeburg
Home
Stocks
Halozyme Therapeutics, Inc. (HALO)
Stock Overview
Annual
Quarterly
Revenue $USD
0
500M
1B
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
100M
200M
300M
400M
500M
Q2 FY23
Q3 FY23
Q4 FY23
Q1 FY24
Q2 FY24
Q3 FY24
Q4 FY24
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Company Profile
No description available
Industry
Biotechnology
Sub-Industry
N/A
Employees
N/A
Founded
N/A
Company Website
N/A
Investor Relations
N/A
CEO
N/A
Headquarters
SAN DIEGO, CA